James Nicoll, a neuropathologist at the University of Southampton, performed autopsies on nine patients who received a plaque-removing vaccine Elan and Wyeth tried in an earlier trial. (Side effects torpedoed that approach.) He found that the vaccine patients had dramatic reductions in plaque compared to a control group.